The new Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR) is tackling one of the biggest global health concerns. By capitalizing on the existing strengths of Tufts schools and Tufts Medical Center and tapping faculty already working in the field from across the university, CIMAR is poised to become an internationally recognized center and trailblazer in AMR management.
Tufts researchers are developing a treatment to prevent the spread of cholera using bacteriophages—viruses that kill the cholera bacteria. Cholera is prevalent in regions with inadequate access to clean water and sanitation, striking almost 3 million people each year worldwide, and kills 95,000.
Phil Haydon was just fifteen years old when he suffered a severe brain injury that resulted in post-traumatic epilepsy. Today he’s the Chair of Tufts School of Medicine’s Department of Neuroscience, and in November of 2021 he plans to set sail from Boston and circumnavigate the globe on a fifty-foot yacht to raise awareness and money for epilepsy research.